The company now expects revenues in the range of $730,000,000 to $750,000,000 for the full year, down from our previous range of $750,000,000 to $770,000,000 Adjusted EBITDA in the range of $190,000,000 to $200,000,000 for the full year, down from the previous range of $200,000,000 to 208,000,000 dollars Capital expenditures in the range of $100,000,000 to $110,000,000 net of reimbursed amounts down from the prior range of $110,000,000 to $120,000,000 as we balance decreased in operating cash. And lastly, we now expect to exit the year with a net debt ratio of 2.25 to 2.5, which compares to our prior target of 2.25 and 2.4 times. In the short term, we could see our net debt ratio move above that range due to working capital needs during the year driven by the timing of reimbursements. Our objective remains to bring down leverage closer to 2 times over the medium term. Based on our current plan, we expect the cadence of adjusted EBITDA in 2024 to track closely with 2023 with over 50% of the adjusted EBITDA in the second half of the year.